Company Profile

Oakgrove Bio LLC
Profile last edited on: 10/27/2022      CAGE: 8HYJ1      UEI: M214G98DEM25

Business Identifier: Tackling effecting a decrease in peptide cost
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

737 Taunton Road
Wilmington, DE 19803
   (302) 584-0019
Location: Single
Congr. District: 00
County: New Castle

Public Profile

An Ag and Health Microbiome startup, the initial effort by Oakgrove Bio management is to develop a recombinant technology platform with the objective being to decrease cost of manufacturing of peptides beyond what is currently commercially feasible. With the firm's principal experienced in the field, the approach is to address peptide production from a different perspective than that of current recombinant peptide production technologies. Specifically, the approachis to take advantage of the fact that peptides can be treated as polymers rather than as folded proteins with a complex structure, novel microbial cell factories will enable the peptide production and purification.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NSF $256,000
Project Title: Cost-Effective Peptide Production Platform

Key People / Management

  Pierre Rouviere -- Founder and principal

Company News

There are no news available.